SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
IMAX Corporation (IMAX) trades at a trailing P/E of 58.3, forward P/E of 21.8. Trailing earnings yield is 1.72%, forward earnings yield 4.58%. PEG 1.86. Graham Number is $10.80.
Criteria proven by this page:
- VALUE (27/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 58.3).
- Forward P/E 21.8 (down from trailing 58.3) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 1.86 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 1.72% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 4.58% as earnings recover.
- Analyst consensus target $42.33 (+14.9% upside) — modest upside expected.
Overall SharesGrow Score: 64/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
27/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — IMAX
Valuation Multiples
P/E (TTM)58.3
Forward P/E21.8
PEG Ratio1.86
Forward PEG0.13
P/B Ratio6.02
P/S Ratio5.00
EV/EBITDA21.1
Per Share Data
EPS (TTM)$0.65
Forward EPS (Est.)$1.69
Book Value / Share$7.97
Revenue / Share$7.64
FCF / Share$2.21
Yields & Fair Value
Earnings Yield1.72%
Forward Earnings Yield4.58%
Dividend Yield0.00%
Graham Number$10.80
SharesGrow IV$46.55 (+26.4%)
Analyst Target$42.33 (+14.9%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
73.7 |
-1.62 |
3.78 |
5.62 |
- |
| 2017 |
645.7 |
-7.12 |
2.87 |
3.97 |
- |
| 2018 |
51.9 |
0.06 |
2.32 |
3.17 |
- |
| 2019 |
26.7 |
0.24 |
2.29 |
3.17 |
- |
| 2020 |
-7.4 |
0.02 |
2.77 |
7.79 |
- |
| 2021 |
-47.2 |
0.56 |
2.96 |
4.14 |
- |
| 2022 |
-36.4 |
-6.92 |
3.15 |
2.76 |
- |
| 2023 |
32.2 |
-0.15 |
2.99 |
2.18 |
- |
| 2024 |
51.7 |
12.15 |
4.50 |
3.83 |
- |
| 2025 |
56.8 |
1.74 |
5.87 |
4.83 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.42 |
$377.33M |
$28.79M |
7.6% |
| 2017 |
$0.04 |
$380.77M |
$2.34M |
0.6% |
| 2018 |
$0.36 |
$374.4M |
$22.84M |
6.1% |
| 2019 |
$0.76 |
$395.66M |
$46.87M |
11.8% |
| 2020 |
$-2.63 |
$137M |
$-143.78M |
-104.9% |
| 2021 |
$-0.16 |
$254.88M |
$-22.33M |
-8.8% |
| 2022 |
$-0.35 |
$300.81M |
$-22.8M |
-7.6% |
| 2023 |
$0.46 |
$374.84M |
$25.34M |
6.8% |
| 2024 |
$0.48 |
$352.21M |
$26.06M |
7.4% |
| 2025 |
$0.63 |
$410.21M |
$34.88M |
8.5% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$1.69 |
$1.37 – $2.16 |
$441.96M |
$419.69M – $455.94M |
7 |
| 2027 |
$1.96 |
$1.63 – $2.24 |
$474.47M |
$444.52M – $497.85M |
6 |
| 2028 |
$2.24 |
$2.19 – $2.31 |
$505.13M |
$502.71M – $507.55M |
3 |
| 2029 |
$2.68 |
$2.50 – $2.81 |
$561.28M |
$531.81M – $581.57M |
1 |
| 2030 |
$3.00 |
$2.80 – $3.14 |
$592.56M |
$561.45M – $613.97M |
1 |
